Data / Form D filings / Reglagene, Inc.
Reglagene, Inc.: Form D filings
Reglagene, Inc., a biotechnology company in Tucson, AZ, filed 6 Form D notices with the SEC between 2018 and 2024. The latest, on May 21, 2024, reports $766,655 sold of a $2.5 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3320 N. CAMPBELL AVE., SUITE 201, Tucson, AZ, 85719
- Phone
- (520) 235-0365
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Arizona
- Year incorporated
- 2024
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1747083
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 21, 2024 | New notice | $2,500,000 | $766,655 | $1,733,345 | 12 | May 16, 2024 | sec.gov |
| Nov 21, 2023 | Amendment | $3,800,000 | $3,794,000 | $6,000 | 22 | Jul 5, 2022 | sec.gov |
| May 17, 2023 | Amendment | $3,000,000 | $1,650,000 | $1,350,000 | 22 | Jul 5, 2022 | sec.gov |
| Jul 5, 2022 | New notice | $5,000,000 | $0 | $5,000,000 | 15 | Jun 27, 2022 | sec.gov |
| Jul 13, 2021 | New notice | $1,500,000 | $600,000 | $900,000 | 3 | Jul 7, 2021 | sec.gov |
| Aug 17, 2018 | New notice | $2,000,000 | $546,413 | $1,453,587 | 11 | Jul 16, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard Austin | Executive Officer, Director |
Other biotechnology companies in Arizona that filed recently
- Gut-Brain-Axis Therapeutics Inc. $2 million · Oct 27, 2026
- Avery Therapeutics, Inc. $8.5 million · Sep 21, 2026
- CND Life Sciences, Inc. $6.3 million · Aug 3, 2026
Every Form D from the week of May 20, 2024 · All recent filings in Arizona · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Reglagene, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.